Dr Reddys Laboratories Share Price Today - Live Blog for September 05, 2025

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.18% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,270.40 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock has surged by 0.18%, and it is currently trading at ₹1,269.25. Additionally, the stock maintains a PE ratio of 18.4100, while the industry PE is 34.7238.

Dr Reddys Laboratories Ltd shares experienced a -0.01% reduction, with the current market price at ₹1,265.50. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd observed a remarkable 0.09% surge in its share price and is presently trading at ₹1,265.60. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd witnessed a -0.04% drop in its share price and is currently trading at ₹1,264.45. With the stock's PE at 18.4100 and the industry PE at 34.7238, investors are weighing their options.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.08% drop, and it's now trading at ₹1,265.00 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd observed a remarkable 0.09% surge in its share price and is presently trading at ₹1,265.95. The increased investor interest is driving this surge.

Following a noteworthy 0.12% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,264.80. When it comes to valuation, this stock has a PE ratio of 18.4100, with the industry PE ratio at 34.7238.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.00% in its share price, and it currently trades at ₹1,263.40 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's shares experienced a 0.41% uptick, and they are currently valued at ₹1,265.50, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd stock remained static, maintaining its position at ₹1,260.30. The stock has a PE ratio of 18.4100, an ROE of 16.8559%, and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd share price surged by 0.01%. With its current market price standing at ₹1,260.30 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd observed a remarkable 0.12% surge in its share price and is presently trading at ₹1,261.45. The increased investor interest is driving this surge.

Demonstrating a commendable 0.12% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,261.45. In terms of valuation, the stock maintains a PE ratio of 18.4100, while the industry PE ratio stands at 34.7238.

After a -0.24% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,260.00. The stock has a PE ratio of 18.4100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd observed a -0.16% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,264.10. The stock has a PE ratio of 18.4100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

With a remarkable 0.03% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,266.10. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.4100, while the industry's PE ratio is 34.7238.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.03%, with its current market value per share resting at ₹1,265.70. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd experienced a substantial 0.31% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,265.45, making it an appealing option for investors.

Dr Reddys Laboratories Ltd share price surged by 0.02%. With its current market price standing at ₹1,263.90 per share, this stock is garnering increased attention from the investment community.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.07%, reaching the current market price of ₹1,263.35. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd experienced a -0.50% dip in its share price and is currently trading at ₹1,261.85. The stock has a PE ratio of 18.4100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

After a notable 0.21% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,268.45. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd's stock price surged by 0.19%, reaching the current market value of ₹1,265.60 per share. This surge is a testament to the stock's recent performance.

With a remarkable 0.53% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,263.20. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.4100, while the industry's PE ratio is 34.7238.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.64%. At this moment, it's actively trading at ₹1,257.45, presenting an enticing opportunity for those in the market.